MoneyControl reports that Biocon is in the final stages of announcing deal to buy Mylan’s biosimilar business

Jan 14, 2022

MoneyControl reported that Biocon is in the final stages of announcing the deal to buy Mylan’s biosimilar business.  In December 2021 MoneyControl reported that Biocon and Mylan were in advanced talks for the creation of a biosimilars spin-off, however neither party has confirmed this speculation.

Print Page Mail Article